Side effect and disease related symptom representations among HIV+ adults on antiretroviral therapy

Psychology, Health and Medicine

Volumn 9, Issue 2, 2004, Pages 139-148

  Johnson, Mallory O ^a   Folkman, S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; EMOTION; EXPERIENCE; FATIGUE; HEALTH CARE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTERVIEW; MAJOR CLINICAL STUDY; NAUSEA; NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME; VOMITING;

EID: 1842634326     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548500410001670672     Document Type: Article

References (49)

1. AMMASSARI, A., MURRI, R., PEZZOTTI, P., TROTTA, M., RAVISIO, L. & DELONIS, P. (2001). Self reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445-449.
2. ATZINGER, A. & DITTMANN, B. J. (1997). [Quality of life and side effects after percutaneous radiotherapy or radical prostatectomy in prostatic carcinoma]. Strahlentherapie und Onkologie, 173(3), 177-178.
3. BANGSBERG, D. R., HECHT, F. M., CHARLEBOIS, E. D., ZOLOPA, A. R., HOLODNIY, M., SHEINER, L., et al. (2000). Adherence to protease inhibitors, HIV- 1 viral load, and development of drug resistance in an indigent population. AIDS, 14(4), 357-366.
4. BATES, C. M. (1996). HIV medicine: drug side effects and interactions. Postgraduate Medical Journal, 72(843), 30-36.
5. BEISECKER, A. E., COOK, M. R., ASHWORTH, J., HAYES, J., BRECHEISEN, M., HELMIG, L., et al. (1997). Side effects of adjuvant chemotherapy: Perceptions of node-negative breast cancer patients. Psycho-Oncology, 6(2), 85-93.
6. BINIK, Y. M., CHOWANEC, G. D. & DEVINS, G. M. (1990). Marital role strain, illness intrusiveness, and their impact on marital and individual adjustment in end-stage renal disease. Psychology & Health, 4(3), 245-257.
7. BOULET, L. P. (1998). Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest, 113(3), 587-592.
8. CARRUTH, A. K. & Boss, B. J. (1990). More than they bargained for: Adverse drug effects. Journal of Gerontological Nursing, 16(7), 27-31.
9. CHESNEY, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30 Suppl 2(3), S171-176.
10. CHESNEY, M. A. & ICKOVICS, J. (1997). Adherence to combination therapy in AIDS clinical trials. Paper presented at the Annual Meeting of the AIDS Clinical Trials Group, Washington, D.C.
11. CHESNEY, M. A., ICKOVICS, J., HECHT, F. M., SIKIPA, G. & RABKIN, J. (1999). Adherence: a necessity for successful HIV combination therapy. AIDS, 13 Suppl A(3), S271-278.
12. CHESNEY, M. A., ICKOVICS, J. R., CHAMBERS, D. B., GIFFORD, A. L., NEIDIG, J., ZWICKL, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255-266.
13. DEVINS, G. M. (1983). The emotional impact of end-stage renal disease: Importance of patients' perceptions of intrusiveness and control. International Journal of Psychiatry in Medicine, 13(4), 327-343.
14. DEVINS, G. M., ARMSTRONG, S. J., MANDIN, H. & PAUL, L. C. (1990). Recurrent pain, illness intrusiveness, and quality of life in end-stage renal disease. Pain, 42(3), 279-285.
15. DEVINS, G. M., MANDIN, H., HONS, R. B. & BURGESS, E. D. (1990). Illness intrusiveness and quality of life in end-stage renal disease: Comparison and stability across treatment modalities. Health Psychology, 9(2), 117-142.
16. DUNBAR-JACOB, J. & SCHLENK, E. A. (1996). Treatment adherence and clinical outcome: Can we make a difference? In R. H. R. E. ROBERT J. RESNICK (Eds), Health psychology through the life span: Practice and research opportunities (pp. 323-343). Washington, DC: American Psychological Association.
17. DUNBAR-JACOB, J. & SEREIKA, S. (2001). Conceptual and methodological problems. In E. LORA, E. BURKE & E. IRA S. OCKENE (Eds), Compliance in healthcare and research (pp. 93-104). Armonk, NY: Futura Publishing Company, Inc.
18. DUNBAR-JACOB, J. M., SCHLENK, E. A., BURKE, L. E. & MATTHEWS, J. T. (1998). Predictors of patient adherence: Patient characteristics. In SALLY A. SHUMAKER, ELEANOR B. SCHRON, et al. (Eds), The handbook of health behavior change (2nd edn) (pp. 491-511): New York, NY: Springer Publishing Company.
19. FIELER, V. K. (1997). Side effects and quality of life in patients receiving high-dose rate brachytherapy. Oncology Nursing Forum, 24(3), 545-553.
20. FINCKE, B. G., MILLER, D. R., & SPIRO, A., 3rd. (1998). The interaction of patient perception of overmedication with drug compliance and side effects. Journal of General Internal Medicine, 13(3), 182-185.
21. HECHT, F. M., COLFAX, G., SWANSON, M. & CHESNEY, M. A. (1998). Adherence and effectiveness of protease inhibitors in clinical practice. Paper presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
22. HORNE, R., & WEINMAN, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatric Research, 47(6). 555-567.
23. IORIO, R., PENSATI, P., BOTTA, S., MOSCHELLA, S., IMPAGLIAZZO, N., VAJRO, P., et al. (1997). Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatric Infectious Disease Journal, 16(10), 984-990.
24. JOHNSON, S. C. & GERBER, J. G. (2000). Advances in HIV/AIDS therapy. Advances in Internal Medicine, 45(1), 1-40.
25. JUSTICE, A. C., CHANG, C. H., RABENECK, L. & ZACKIN, R. (2001). Clinical importance of provider-reported HIV symptoms compared with patient-report. Medical Care, 39(4), 397-408.
26. KELLER, S. D., MAJKUT, T. C., KOSINKI, M. & WARE, J. E. Jr. (1999). Monitoring health outcomes among patients with arthritis using the SF-36 Health Survey: overview. Medical Care, 37(5 Suppl), MS1-9.
27. LARRISON, E. H. (1999). Management of side effects in patients with recurrent ovarian cancer. Seminars in Oncology, 26(1 Suppl 1), 15-31.
28. LEVENTHAL, H., BENYAMINI, Y., BROWNLEE, S., DIEFENBACH M., LEVENTHAL, E. A., PATRICK-MILLER, L. et al. (1997). Illness representations: Theoretical foundations. In J. P. KEITH, JOHN A. WEINMAN, et al. (Eds), Perceptions of health and illness: Current research and applications (pp. 19-45).
29. LEVENTHAL, H., DIEFENBACH, M. & LEVENTHAL, E. A. (1992a). Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy & Research, 16(2). 143-163.
30. LEVENTHAL, H., LEVENTHAL, E. A. & SCHAEFER, P. M. (1992b). Vigilant coping and health behavior. In M. G. ORY, R. P. ABELES, et al. (Eds), Aging, health, and behavior (pp. 109-140). Thousand Oaks, CA, US: Sage Publications, Inc.
31. LEVENTHAL, H., MEYER, D. & NERENZ, D. (1980). The commonsense representations of illness danger. In S. RACHMAN (Ed), Contributions to Medical Psychology (Vol. 2, pp. 17-30). New York: Pergamon Press.
32. LEVENTHAL, H., NERENZ, D. R. & STEELE, D. J. (1984). Illness representations and coping with health threats. In A. BAUM, S. E. TAYLOR & J. E. SINGER (Eds), Handbook of psychology and health (Vol. 4, pp. 219-252). Hillsdale, NJ: Lawrence Erlbaum Associates.
33. LONGMAN, A. J., BRADEN, C. J. & MISHEL, M. H. (1999). Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. Oncology Nursing Forum, 26(5), 909-915.
34. MACQUART-MOULIN, G., VIENS, P., GENRE, D., BOUSCARY, M. L., RESBEUT, M., GRAVIS, G., et al. (1999). Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization. Cancer, 85(10), 2190-2199.
35. MCHORNEY, C. A., WARE, J. E., Lu, J. F. R. & SHERBOURNE, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32(1), 40-66.
36. MCHORNEY, C. A., WARE, J. E. & RACZEK, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247-263.
37. MEYER, D., LEVENTHAL, H. & GUTMANN, M. (1985). Common-sense models of illness: the example of hypertension. Health Psychol, 4(2), 115-135.
38. MOHR, D. C., LIKOSKY, W., BOUDEWYN, A. C., MARIETTA, P., DWYER, P., VAN DER WENDE, J., et al. (1998). Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a. Multiple Sclerosis, 4(6), 487-489.
39. MOSS-MORRis, R., WEINMAN, J., PETRIE, K. J., HORNE, R., CAMERON, L. D. & BUICK, D. (2002). The revised Illness Perception Questionnaire (IPQ-R). Psychology & Health, 17(1), 1-16.
40. MURPHY, E. L., COLLIER, A. C., KALISH, L. A., ASSMANN, S. F., PARA, M. F., FLANIGAN, T. P., et al. (2001). Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Viral Activation Transfusion Study Investigators. Annals of Internal Medicine, 135(1), 17-26.
41. PAPADOPOULOS, L., BOR, R., WALKER, C. & LEGG, C. (2001). The Illness Perception Questionnaire as a reliable assessment tool: Cognitive representations of vitiligo. Psychology Health & Medicine, 6(4), 441-446.
42. PAYNE, R., MATHIAS, S. D., PASTA, D. J., WANKE, L. A., WILLIAMS, R., & MAHMOUD, R. (1998). Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. Journal of Clinical Oncology, 16(4), 1588-1593.
43. SEARL, A. & MURPHY, S. (2000). Representations of illness: Their relationship with an understanding of and adherence to homoeopathic treatment. Psychology Health & Medicine, 5(2), 179-191.
44. STEED, L., NEWMAN, S. P., & HARDMAN, S. M. C. (1999). An examination of the Self-Regulation Model in atrial fibrillation. British Journal of Health Psychology, 4(4), 337-347.
45. TALLEY, S. L. (1999). Self-regulation activities used by individuals with schizophrenia. Dissertation Abstracts International: Section B: the Sciences & Engineering, 59(12-B), 6265.
46. WARE, J. E., GANDEK, B. & The IQOLA Project Group. (1994). The SF-36 Health Survey: Development and use in mental health research and the IQOLA Poject. International Journal of Mental Health, 23(2), 49-73.
47. WARE, J. E., Jr. (1999). SF-36 Health Survey. In MARK MARUISH (Ed.), The use of psychological testing for treatment planning and outcomes assessment (2nd edn) (pp. 1227-1246): Mahwah, NJ: Lawrence Erlbaum.
48. WARE, J. E., Jr. & GANDEK, B. (1998). Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology, 51(11), 903-912.
49. WEINMAN, J., PETRIE, K. J., MOSS-MORRIS, R. & HORNE, R. (1996). The Illness Perception Questionnaire: A new method for assessing the cognitive representation of illness. Psychology & Health, 11(3). 431-445.